| |
CD4:CD8 ratio
|
CD3CD4 (%)
|
CD3CD4 106cells/L
|
CD3CD8 (%)
|
CD3CD8 106cells/L
|
CD16CD56 (%)
|
CD16CD56 106cells/L
|
|---|
|
no-fatigue controls (n = 32)
|
2.43 (0.97)
|
51.1 (8.2)
|
990 (376)
|
22.9 (5.5)
|
440 (198)
|
11.7 (6.7)
|
210 (99)
|
|
PI-CFS/ICF (n=24)
|
2.05 (0.76)
|
50.5 (7.0)
|
939 (366)
|
27.0 (7.0)
|
497 (207)
|
7.5 (3.5)**
|
130 (54)**
|
|
PI-CFS (n = 19)
|
2.01 (0.77)
|
50.3 (6.9)
|
912 (296)
|
27.5 (7.0)*
|
497 (200)
|
8.0 (3.6)*
|
138 (55)**
|
|
Fatigue other cause (n=12)
|
2.37 (1.14)
|
51.9 (8.1)
|
1132 (543)
|
26.1 (10.4)
|
635 (531)
|
8.7 (4.6)
|
186 (139)
|
|
Fatigue recovered (n=12)
|
1.80 (0.82)*
|
46.1 (10.3)
|
834 (318)
|
28.8 (9.1)*
|
545 (225)
|
10.6 (9.0)
|
203 (188)
|
|
no-FGID (n=26)
|
2.74 (1.06)
|
53.3 (8.6)
|
1008 (363)
|
21.1 (5.4)
|
394 (167)
|
11.3 (7.1)
|
192 (80)
|
|
All FGID (n=54)
|
1.96 (0.75)**
|
48.9 (7.7)*
|
958 (415)
|
27.6 (7.6)***
|
555 (311)**
|
9.1 (5.6)
|
176 (129)
|
|
PI-FGID (n=45)
|
2.00 (0.78)**
|
49.2 (7.9)*
|
949 (418)
|
27.1 (7.35)**
|
537 (313)*
|
8.8 (5.4)
|
169 (122)
|
|
PI-IBS (n=23)
|
1.97 (0.91)**
|
49.5 (8.8)
|
988 (463)
|
28.2 (7.1)**
|
592 (376)*
|
8.1 (5.0)*
|
157 (111)
|
|
no-FGID/no-fatigue controls (n=23)
|
2.65 (1.05)
|
52.4 (8.8)
|
974 (380)
|
21.5 (5.5)
|
389 (171)
|
11.8 (7.6)
|
194 (86)
|
|
FGID&CFS/ICF(n=23)
|
2.01 (0.75)*
|
50.2 (7.0)
|
923 (366)
|
27.3 (6.9)**
|
500 (211)
|
7.4 (3.5)**
|
127 (53)*
|
|
FGID, no fatigue (n=21)
|
1.82 (0.65)**
|
46.9 (8.5)*
|
924 (356)
|
27.9 (7.3)**
|
548 (214)**
|
11.0 (7.0)
|
223 (156)
|
|
Fatigue other cause w/wo FGID (n=12)
|
2.37 (1.14)
|
51.9 (8.1)
|
1133 (543)
|
26.1 (10.4)
|
635 (531)
|
8.7 (4.6)
|
186 (140)
|
-
* p < 0.05 level compared to the control group (in italics) in each categorization.
-
** Significant at p<0.01 level compared to the control group (in italics) in its categorization.
-
*** Significant at p<0.001 level compared to the control group (in italics) in its categorization.
- CD4:CD8 T-cells ratio, CD4 and CD8 T-cell subsets, CD16CD56 natural killer cells percentages and concentrations by analysis categorizations and relevant subgroups. All values are given as mean (SD). Data for the subgroups of PI-CFS, PI-FGID and PI-IBS are also given (indented).
